|
About
the Workshop Leader
Irwin
Silverstein, Ph.D.,
is Chief Operating Officer of International
Pharmaceutical Excipients Auditing Inc.
(IPEA). Previously he was corporate director
of quality assurance for International Specialty
Products with responsibility for excipient,
API, and medical device products. He has
worked over 13 years with the International
Pharmaceutical Excipients Council of the
Americas (IPEC-America) developing excipient
GMP guidance documents and representing
the organization at Food & Drug Administration
meetings and various conferences.
Dr.
Silverstein holds both an American Society
for Quality (ASQ) Certified Quality Auditor
(CQA) and ISO 9000 Certified Lead Auditor
(CLA) status. In addition, Dr. Silverstein
is president of his own firm, IBS Consulting
in Quality, LLC, which specializes in quality
assurance and regulatory compliance for
pharmaceutical excipient ingredients. Using
his 20 years of experience in pharmaceutical
ingredient quality systems, Dr. Silverstein
also has become a consultant to both pharmaceutical
and excipient manufacturing companies.
Dr.
Silverstein has authored numerous articles
in industry journals on excipient GMP compliance
and auditing. Most recently, his articles
have appeared in American Pharmaceutical
Review (June) and Tablets & Capsules
(July). Also of note is an article on Quality
for the Kirk-Othmer Encyclopedia of Chemical
Technology and a chapter on excipients in
Validation of Active Pharmaceutical Ingredients.
|